2013-05-14
Additional Preliminary Injunction Obtained Against Boston Scientific in Germany
2013-05-13
COMBO Dual Therapy Stent Clinical Results to Be Featured at EuroPCR 2013
2013-05-08
OrbusNeich enforces injunction against Boston Scientific in Germany
2013-04-30
Preliminary injunction obtained in patent infringement proceedings in Germany against Boston Scientific
2013-04-22
Cardiovascular Summit TCTAP 2013 Symposium to Feature COMBO Dual Therapy Stent
2013-04-16
Data Published in JACC: Cardiovascular Interventions Show that COMBO Dual Therapy Stent Reaches Primary Study Endpoint and Is Effective in Controlling Neointimal Proliferation
2013-04-01
COMBO Dual Therapy Stent to Be Featured in Symposium at the 79th Annual Meeting of the German Cardiac Society in Mannheim
2013-03-25
COMBO Stent to Be Featured at Interventional Cardiology 2013: 28th Annual International Symposium
2013-03-08
Patent Infringement Lawsuit Filed Against Boston Scientific in Ireland
2013-02-22
COMBO Dual Therapy Stent to Be Featured at CRT 2013
2013-02-21
Patent Infringement Actions Filed Against Boston Scientific in Germany and the Netherlands
2013-02-20
COMBO Dual Therapy Stent to Be Featured During Chugoku Shikoku Live in Kurashiki 2013
2013-02-13
OrbusNeich Announces Favorable Ruling From the European Patent Office
2013-02-11
COMBO Dual Therapy Stent to Be Featured During Joint Interventional Meeting (JIM) 2013 Symposium
2013-01-21
COMBO Dual Therapy Stent to Be Featured During AsiaPCR/SingLIVE 2013 Symposium
2012-12-17
Case of a Patient with Acute Myeloid Leukemia Treated with a Genous Stent Published in the Journal ‘Leukemia’
2012-10-16
COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012
2012-10-12
Revascularization with Genous Stent May Enable the Safe and Early Discontinuation of Dual Antiplatelet Therapy for Patients with Increased Bleeding Risk
2012-06-21
Genous Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement
2012-05-17
Early Healing Advantage of COMBO Stent Compared to TAXUS Shown in Two Trial Subgroup Analyses
2012-05-15
COMBO Dual Therapy Stent Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up
2012-05-11
Genous Stent Is a Safe and Effective Alternative for Patients with Contraindications to Drug Eluting Stents (DES)
2012-05-08
Clinical Data for OrbusNeich’s COMBO Dual Therapy Stent Set for Presentation at EuroPCR 2012
2012-04-25
COMBO Dual Therapy Stent Featured During Symposium at Angioplasty Summit TCTAP 2012
2012-04-23
OrbusNeich Hosts Symposium at Angioplasty Summit TCTAP 2012: “The Next Era: COMBO Dual Therapy Stent”
OrbusNeich Hosts Symposium at Angioplasty Summit TCTAP 2012: “The Next Era: COMBO Dual Therapy Stent
2012-04-20
OCT Case Report: Genous Stent Achieves Complete Endothelialization at Two Weeks
2012-04-04
Bifurcation Stenting with Genous Stent Shows Favorable Clinical Outcomes with Low Rates of Repeat Revascularization and Stent Thrombosis at 12 Months
2012-03-27
Data Presented at ACC.12 Demonstrate that Genous Stent is Feasible and Safe in STEMI Patients
2012-03-22
Genous Technology Effectively Promotes Endothelialization and Reduces Thrombogenicity
2012-03-07
Genous Stent is a Safe and Effective Option in Patients with ST-Segment Elevation Myocardial Infarction
2012-01-05
Genous Achieves Good, Comparable Clinical Outcomes in Patients discontinuing DAPT at 30 Days and at 6 Months
2011-12-20
Use of Genous Stent in Bifurcations Is Feasible and Safe with No Incidence of Late Stent Thrombosis
2011-12-09
Genous Stent Is an Effective Treatment Option for Acute Coronary Syndrome with Stent Thrombosis After Fracture of a Drug Eluting Stent (DES)
2011-12-05
Data Published in EuroIntervention Indicate that Genous Stent Is Safe with Very Short-Term DAPT
2011-11-14
REMEDEE Study Meets Primary Endpoint: COMBO Dual Therapy Stent Is Non-Inferior to DES
2011-11-10
OrbusNeich Introduces the COMBO Dual Therapy Stent at TCT 2011
2011-11-09
Genous Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to BMS and DES at 14 Days
2011-11-08
Three-Year Clinical Outcomes from Use of Genous Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy
2011-11-01
Data from REMEDEE Trial Featuring OrbusNeich’s COMBO™ Dual Therapy Stent to Be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011
2011-10-25
Data Published in Circulation Journal Show Genous™ Stent Is Safe and Effective in Elderly Patients
2011-08-16
Two-Year Follow-Up Data Show Outstanding Clinical Outcomes and Safety for Genous Stent in Patients at High Risk for Restenosis
2011-07-18
Genous Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery
2011-07-11
Study Confirms Genous Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity
2011-05-19
Genous Stent is Safe and Effective in Cases Where Prolonged Dual Antiplatelet Therapy is Not Advisable as Presented at EuroPCR 2011
2011-05-12
Data From Multiple Clinical Trials of Genous Stent Set for Presentation at EuroPCR 2011
2011-04-15
Revascularization with Genous™ Stent May Allow Reduced Waiting Time for Lung Resection by Decreasing Duration of Dual Antiplatelet Therapy
2011-03-28
Positive Long-term Safety and Efficacy Demonstrated for Genous Stent in Large, Unselected Patient Population with Mostly Complex Lesions and Estimated High Risk for Restenosis
2011-03-23
Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeich’s Genous™ Stent in Diabetic Patients
2011-03-21
OrbusNeich Files Lawsuit Against Dr. Pavel Cervinka for Defamation
2011-03-14
OrbusNeich Announces Availability of Azule™ Cobalt Chromium Stent
2011-02-28
OrbusNeich Announces Availability of Next-Generation Sapphire™ II Coronary Dilatation Catheter
2011-02-22
Published Data from e-HEALING Registry Demonstrate Good Clinical Outcomes with Low Incidence of Repeat Revascularization and Stent Thrombosis for Genous Stent
2011-02-16
GATEWAY Registry Initiated in U.K. to Investigate Genous™ Stent in Patients with Acute Coronary Syndrome (ACS) and High-Risk of Post-Procedural Bleeding
2011-01-10
Safety and Efficacy of Genous Stent Demonstrated in High-Risk Patients with Known Contraindications for Dual Antiplatelet Therapy
2011-01-04
OrbusNeich Granted Expanded U.S. Patent of Genous Endothelial Progenitor Cell Capture Technology
2010-12-02
Genous Stent Shows Favorable Outcomes for Treatment of Coronary Artery Bifurcation Lesions Compared to Bare Metal Stents
2010-12-01
OrbusNeich Issues Statement on Boston Scientific’s Unsuccessful Retaliatory Litigation Efforts in The Netherlands
2010-11-23
Unique Studies with Genous Stent Further Validate Early EPC Coverage and Reduced Thrombogenicity in Human Circulating Blood Compared to BMS
2010-10-11
Randomized Clinical Trial of Genous Bio-engineered R stent in China Completes Patient Enrollment
2010-09-25
Data from Multiple Clinical Trials of Genous Stent Presented at TCT
2010-09-24
Patient Enrollment Completed in First Randomized Clinical Study of COMBO Bio-engineered Sirolimus Eluting Stent
Genous Bio-engineered R stent Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease
2010-08-23
100 Percent Coverage of Struts and Complete Neointimal Coverage of Genous Stents Demonstrated 26 Days Post-Implantation in STEMI Patient
2010-07-02
COMBO Bio-engineered Sirolimus-Eluting Stent Featured in Live Case Demonstration at AICT
2010-06-21
Data Show Genous Bio-engineered R stent is Safe and Effective in Combination with Drug-Eluting Balloon
2010-05-26
Data Presented at EuroPCR 2010 Demonstrate Effectiveness of OrbusNeich's Genous™ Bio-engineered R stent™ in Diabetic Patients
2010-04-29
Genous Bio-engineered R stent Demonstrates Excellent Safety and Clinical Outcomes in High-Risk Elderly Patients
2010-04-20
News Release - OrbusNeich Announces Full Availability of Genous™ Bio-engineered Cobalt Chromium Stent Following CE Mark Approval
2010-04-15
News Release - OrbusNeich Granted Patent for “Stent with Helical Elements”- Patent Infringement Case Against Boston Scientific Expanded
2010-03-17
News Release - Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeich's Genous™ Bio-engineered R stent™
2010-02-15
News Release - Clinical Data Presented at JIM 2010 Provide Further Evidence that the Genous™ Bio-engineered R stent™ Could Be a Treatment of Choice for Patients Not Suitable for Long Term Dual Antiplatelet Therapy
2010-02-11
News Release - OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous™ Bio-engineered R stent™ in China
2010-02-01
News Release - OrbusNeich’s Genous™ Bio-engineered R stent™ Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
2010-01-23
News Release - Clinical Data Presented at Asia PCR/Sing LIVE Demonstrate Benefits of OrbusNeich’s Genous™ Bio-engineered R stent™ in Challenging Patient Subsets
2009-12-09
News Release - Al Novak Elected Chairman of the Board of OrbusNeich Medical
2009-12-01
News Release - OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the COMBO Bio-engineered Sirolimus Eluting Stent
2009-09-23
News Release - Pre-clinical Data Show OrbusNeich’s COMBO Bio-engineered Sirolimus Eluting Stent May Offer Advantages to Current Drug Eluting Stent Technologies
2009-09-22
News Release - OrbusNeich’s Genous™ Bio-engineered R Stent™ is Safe in a Broad Population of Patients with Primary PCI for STEMI
